Quarterly Snapshot: Quick and Current Ratios for Sage Therapeutics Inc (SAGE)

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Sage Therapeutics Inc (NASDAQ: SAGE) was $6.59 for the day, up 3.45% from the previous closing price of $6.37. In other words, the price has increased by $3.45 from its previous closing price. On the day, 0.66 million shares were traded. SAGE stock price reached its highest trading level at $6.78 during the session, while it also had its lowest trading level at $6.2.

Ratios:

Our analysis of SAGE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 9.95 and its Current Ratio is at 9.95. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

On October 04, 2024, RBC Capital Mkts Downgraded its rating to Sector Perform which previously was Outperform and also lowered its target price recommendation from $10 to $4.

TD Cowen Downgraded its Buy to Hold on July 30, 2024, whereas the target price for the stock was revised from $16 to $10.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SAGE now has a Market Capitalization of 402322144 and an Enterprise Value of -243059744. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.14 while its Price-to-Book (P/B) ratio in mrq is 0.64. Its current Enterprise Value per Revenue stands at -2.5 whereas that against EBITDA is 0.542.

Stock Price History:

Over the past 52 weeks, SAGE has reached a high of $28.26, while it has fallen to a 52-week low of $5.84. The 50-Day Moving Average of the stock is -14.48%, while the 200-Day Moving Average is calculated to be -54.96%.

Shares Statistics:

SAGE traded an average of 741.07K shares per day over the past three months and 610560 shares per day over the past ten days. A total of 60.04M shares are outstanding, with a floating share count of 50.28M. Insiders hold about 17.64% of the company’s shares, while institutions hold 88.73% stake in the company. Shares short for SAGE as of 1727654400 were 5709072 with a Short Ratio of 7.70, compared to 1724976000 on 6216427. Therefore, it implies a Short% of Shares Outstanding of 5709072 and a Short% of Float of 10.6000006.

Most Popular